FDA Advisory Committee Recommends Approval Of Daiichi Sankyo’s Savaysa (edoxaban) November 14, 2014 Filed under: Trends-in-Medicine
FDA Advisory Committee Recommends Approval of Novartis’ Cosentyx (Secukinumab) to Treat Psoriasis October 31, 2014 Filed under: Trends-in-Medicine
FDA Advisory Committee Neutral on Boston Scientific’s Watchman October 31, 2014 Filed under: Trends-in-Medicine